Journal of Urology

Papers
(The H4-Index of Journal of Urology is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Urological Oncology: Bladder, Penis and Urethral Cancer, and Basic Principles of Oncology349
Urological Oncology: Prostate Cancer261
Editorial Comment254
MP12-03 IL-7 AND CCL19 PRODUCING CAR-T CELLS PREVENT ANTIGEN-LOSS TUMOR RELAPSE AND ENHANCE ANTITUMOR EFFICACY AGAINST SOLID CANCER250
MP54-13 THE UPDATE FROM BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT FOR LOW-GRADE BLADDER TUMORS: LONG-TERM ONCOLOGICAL OUTCOMES OF PATIENTS UNDER ACTIVE SURVEILLANCE216
PD40-10 FORMAL VALIDATION AT FINAL PATHOLOGY AFTER RADICAL NEHRECTOMY OF NEPHROMETRY SCORES: DISCORDANCE RATES AND OVERTREATMENT RISK209
PD23-04 EXPLORING ACTINIDIN AS A NOVEL COLLAGENASE TO TREAT HUMAN PEYRONIE’S DISEASE CELLS190
MP46-04 10-YEAR EXPERIENCE WITH MIDLINE EXTRAPERITONEAL RETROPERITONEAL LYMPH NODE DISSECTION181
MP21-16 DEMOGRAPHICS AND INCIDENTAL DIAGNOSES OF MEN WITH PRIAPISM147
PD35-06 HEALTH-RELATED QUALITY OF LIFE IN LOW-INCOME MEN AFTER SURGICAL CASTRATION FOR METASTATIC PROSTATE CANCER121
MP40-04 PREDICTIVE RISK FACTORS FOR EARLY RECURRENCE AFTER RADICAL NEPHROURETERECTOMY FOR LOW-GRADE UPPER TRACT UROTHELIAL CARCINOMA115
MP21-11 SEVERITY OF PENILE CURVATURE IN PEYRONIE’S DISEASE DOES NOT CORRELATE WITH SHIM OR PDQ SCORES113
This Month in Adult Urology113
LBA02-02 DEVELOPMENT OF A MULTIPHASIC BLADDER PATCH COMPOSED OF COLLAGEN, AMNIOTIC MEMBRANE, AND PATIENT-DERIVED EPITHELIAL CELLS108
PD39-05 PROSTATE MEASUREMENT ON COMPUTED TOMOGRAPHY: VARIANCE DECREASES AS PROSTATE VOLUME INCREASES98
MP11-04 PELVIC ORGAN PROLAPSE IS NOT UNCOMMON AMONG WOMEN WITH SPINA BIFIDA92
V07-04 SINGLE PORT TRANSVESICAL PARTIAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER85
MP34-01 IS TESTIS SPARING SURGERY A SAFE APPROACH IN PATIENTS WITH SMALL TESTICULAR LESIONS REFERRING TO A FERTILITY CENTER? A RETROSPECTIVE ANALYSIS REPORTING LONG-TERM ONCOLOGICAL OUTCOMES AND FACTO85
PD15-05 PROGNOSTIC VALUE OF EARLY DYNAMIC CHANGE OF NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IN PATIENTS WITH UPPER-TRACT UROTHELIAL CARCINOMA (UTUC) TREATED WITH NEPHROURETERECTOMY76
PD18-08 PROGNOSTIC VALUE OF NEUTROPHIL-TO-LYMPHOCYTE RATIO AND PLATELET-TO-LYMPHOCYTE RATIO FOR SMALL RENAL CELL CARCINOMAS AFTER IMAGE-GUIDED CRYOABLATION (CRYO) OR RADIO-FREQUENCY ABLATION (RFA)72
PD23-09 AUXETIC EXPANSION OF THE TUNICA ALBUGINEA FOR PENILE LENGTH AND GIRTH RESTORATION WITHOUT A GRAFT: A CASE SERIES.65
MP05-16 NEW PERSPECTIVES ON AN OLD GROUPING: THE GENOMIC AND PHENOTYPIC DIFFERENCES OF OXALOBACTER FORMIGENES65
MP24-01 RACE BASED EQUATIONS FOR ESTIMATING KIDNEY FUNCTION MAY CONTRIBUTE TO RACIAL DISPARITIES IN PARTIAL NEPHRECTOMY UTILIZATION AMONG BLACK PATIENTS WITH KIDNEY TUMORS64
PD19-03 ASSESSMENT OF FACTORS INVOLVED IN LASER FIBER DEGRADATION WITH THULIUM FIBER LASER60
MP45-07 ONCOLOGIC OUTCOMES OF TOTAL LENGTH GLEASON PATTERN 4 ON BIOPSY IN MEN WITH GRADE GROUP 2 PROSTATE CANCER59
MP17-03 COMPLICATION RATES AMONG DIFFERENT TREATMENT MODALITIES FOR THE SURGICAL MANAGEMENT OF VESICOURETERAL REFLUX IN CHILDREN59
MP56-17 RADICAL CYSTECTOMY VIDEO CONSENSUS: A SIMPLE AND EFFECTIVE WAY TO IMPROVE AWARENESS OF PATIENTS UNDERGOING RADICAL CYSTECTOMY59
MP58-16 DOES VETERAN STATUS MITIGATE RACIAL DISPARITIES IN PROSTATE CANCER SCREENING? ANALYSIS OF PROSTATE-SPECIFIC ANTIGEN SCREENING PATTERNS IN THE 2018 BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM DA57
PD55-02 PREDICTION OF CHEMICAL COMPOSITION OF URINARY STONE THROUGH DEEP LEARNING56
PD08-02 URINARY DIVERSION FOR INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME: PREVALENCE AND PERIOPERATIVE COMPLICATION RATE55
MP26-09 ACCURACY OF DIAGNOSTIC CODES IN A CLINICAL RESEARCH NETWORK TO IDENTIFY PRIMARY HYPEROXALURIA PATIENTS55
PD58-08 SURVIVAL OUTCOMES IN SOLITARY KIDNEY PATIENTS DIAGNOSED WITH UPPER TRACT UROTHELIAL CARCINOMA55
MP14-17 MORTALITY ASSOCIATED WITH SEPSIS POST-URETEROSCOPY AMONG A US-BASED COMMERCIAL POPULATION55
MP06-18 A GENOMIC URINE ASSAY TO DETECT URINARY TRACT RECURRENCES IN PATIENTS WITH BLADDER CANCER TREATED WITH RADIOTHERAPY54
MP33-09 RADIOGENOMIC CORRELATES OF CLINICALLY RELEVANT CLEAR CELL RENAL CELL CANCER BIOMARKERS54
MP56-19 TRIMODAL THERAPY VERSUS RADICAL CYSTECTOMY FOR T2 BLADDER CANCER: REAL-WORLD EVIDENCE FROM ONTARIO52
MP47-08 SURGICAL DELAY AFTER BIOPSY AND RISK OF UPSTAGING FOR CLINICAL T1A RENAL CELL CARCINOMA52
MP24-13 IMPACT OF PRIMARY TUMOR SIZE ON CANCER-SPECIFIC AND ALL-CAUSE MORTALITY IN PATIENTS UNDERGOING CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA: ANALYSIS FROM THE INTERNATIONAL MA49
MP11-12 PRENATAL DIAGNOSIS OF BLADDER AND CLOACAL EXSTROPHY OVER 20 YEARS47
PD41-12 FROM BIOPSY TO DIAGNOSIS IN 30 MIN: REMOTE INSTANT PROSTATE PATHOLOGY BASED ON ARTIFICIAL INTELLIGENCE ENHANCED ULTRASOUND (AI-US)46
PD53-06 CHANGES IN MOUSE STOOL MICROBIOME WITH EXPOSURE TO BLADDER CARCINOGEN N-BUTYL-N-(4-HYDROXYBUYTL) NITROSAMINE (BBN): LONGITUDINAL ANALYSIS43
V11-06 DYNAMIC SENTINEL LYMPH NODE BIOPSY FOR PENILE CANCER: ACCURACY IS IN THE TECHNIQUE43
PD13-01 THE CONTINUING IMPACT OF THE COVID-19 PANDEMIC ON PROSTATE CANCER MANAGEMENT: A POPULATION BASED ANALYSIS43
0.045439004898071